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Infection with the malmia pm·asites is one of the major infectious causes of mo11ality in worldwide. Management of the infection is increasingly compromised by the incessant spread of drug resistm1ce. It is necessmy to identify new exploitable therapeutic tm~gets m1d discover potential inhibitors for these targets. Lactate dehyrogenase enzyme of malaria pmasite plays an important role in regulating glycolysis. The enzyme possesses distinctive features in its·· physicochemical and biochemical prope11ies as compmed to the host enzyme. vVe have pmified a recombinm1t lactate dehydrogenase (LDH) of Plasnwdiumfalciparwn to explore the possibility of using this enzyme as a tm·get for structure based drug design. Protein is pmified fi·om the .soluble extract of Escherichia coli using anion exchange chromatography on Q-Sepharose followed by c!u·omatography on Blue Sephmose m1d HPLC gel filtration. Pmified protein is active in an NADH dependent LDH assay. The protein is crystallized using hanging drop vapor diffusion technique with PEG 20,000 as precipitant at pH 6.3 -6.7 m1d 10% (v/v) glycerol as an additive. We m·e attempting to apply protein crystallography towm·ds the design of m1tifungal agents. Fungal pathogens have become a se1ious problem because of their acquired resistance to existing antifungal agents (1). Ag1iculture, where fungi cm1 cause crop losses both before m1d after the hm-vest would benefit greatly from an improved fungicide. The worldwide sales of antifungal agents is estimated to be close to $5 billion US (2). Fungal pathenogens m·e also an important problem for people with compromised immune systems such as AIDS victims, burn patients, and chemotherapy subjects.
The approach we are using is known as structure based drug design (3); it provides the resem-cher with the a priori knowledge necessmy for a rational semch for drug compounds. Structure based drug design requires a thorough understanding of the underlying biochemistry of the pathology. An impm1ant conuibution to tllis understanding is the dete1mination of the tJu·ee dimensional Stll!Cture of the biological molecule with which tl1e drug molecule interacts; such information is obtained by the technique of X-ray C!ystallography.
An excellent target for structure based drug design is tl1e altered anlino acid metabolism of fungi. The pathway shown generates essential anlino acids for the fungus, but has no conesponding pathway in m1imals (animals obtain the required m11ino acids tJu·ough their diet). We have selected tl1e homose1ine dehydrogenase (HSD) enzyme as a subject for Stl"Uctural detem1ination. HSD was chosen for two reasons:
( 1) The protein can be obtained in lmge qum1tities-m1 overexpression vector and a pmification scheme have already been established.
(2) It is known that 2-amino-4-oxo-5-hydroxypentanoic acid inhibits fungal growth by interacting with HSD (4).
We have c1ystallized the HSD protein as plates which diffract to 2.5 Angstromn 1 resolution. The enzyme has been cocrystallized with the NAD+ cofactor and also with an NAD+ m1alogue m1d the substrate L-homoserine. Data collection for these Clystals is currently underway. The first su·ucture of an aldehyde dehydrogenase (class 3, 452 residues) from rat liver has been determined at 2.6A resolution using SIRAS data and solvent flattening. There are two molecules in the c1ystallographic asymmetric unit which self-associate to form a homodimer. The structure shows two open uJ0 domains. The NAD binding domain (residues 1-200) shows a variant Rossmann fold with the glycine-1ich segment at the end of 0-su·and4 instead of at the end of 0-su·and 1 found in compm·able enzymes. The u·m1sition to tl1e catalytic domain is punctuated by a highly conse1-ved Gly-Gly segment, residues 211-212. The catalytic domain (residues 20 1-400) bears an intriguing resemblance to the catalytic domain of dihydrofolate reductase. The apparent aldehyde binding site contains the strictly conserved catalytic Cys243 and the highly conserved Glu209. Another interesting feature of the structure is a 55 residue segment at C-tem1inus which extends back from the catalytic domain over the co-enzyme binding domain with the final 30 residues completing of the catalytic domain oftl1e relatedALDH molecule in the homodimer. Details of the st!l.Jcture and its implications to the Class 1 and 2 stmctures will be presented.
Work supported by a gr<mtAA06985 from the National Institute of Alcohol Abuse and Alcoholism, and resources from the Pittsburgh Supercomputing Center. Inosine monophosphate dehydrogenase (IMPDH) catalyzes the NAD-dependent oxidation of inosine monophosphate (IMP) to xm1-tl1ine monophosphate (XlYIP). This is the rate-linliting step in purine biosyntl1esis. Inhibitors of this enzyme have been shown to have anti-tumor, immunosuppressive, and antiparasitic effects.
The enzyme is a tetrm11er of 230 kD total weight. C1ystals of the recombinant enzyme were grown in 2.2 M ammonium sulfate m1d c1ystallized in the cubic space group P432. Data were collected at bean1lines 1-5 and7-1 at SSRL, and at bean11ine Flat CHESS.
